Myomo (MYO) Property, Plant & Equipment (Net) (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.43% |
| Sep 30, 2025 | 27.71% |
| Jun 30, 2025 | 57.89% |
| Mar 31, 2025 | 38.51% |
| Dec 31, 2024 | 136.94% |
| Sep 30, 2024 | 94.03% |
| Jun 30, 2024 | 40.49% |
| Mar 31, 2024 | 17.14% |
| Dec 31, 2023 | 2.20% |
| Sep 30, 2023 | 11.90% |
| Jun 30, 2023 | -19.41% |
| Mar 31, 2023 | -1.83% |
| Dec 31, 2022 | -19.03% |
| Sep 30, 2022 | -15.31% |
| Jun 30, 2022 | 1.35% |
| Mar 31, 2022 | 1.54% |
| Dec 31, 2021 | -8.88% |
| Sep 30, 2021 | -5.66% |
| Jun 30, 2021 | 52.28% |
| Mar 31, 2021 | 121.31% |
| Dec 31, 2020 | -10.01% |
| Sep 30, 2020 | -3.91% |
| Jun 30, 2020 | -21.07% |
| Mar 31, 2020 | -10.17% |
| Dec 31, 2019 | -9.02% |
| Sep 30, 2019 | -11.55% |
| Jun 30, 2019 | 11.26% |
| Mar 31, 2019 | -7.70% |
| Dec 31, 2018 | -5.71% |
| Sep 30, 2018 | 21.37% |
| Jun 30, 2018 | 5.49% |
| Mar 31, 2018 | 101.32% |
| Dec 31, 2017 | 253.54% |
| Sep 30, 2017 | -0.83% |